the next step shows a way to make these tradeoffs feel less like guesswork and more like a plan
This could lead to reduced demand for snacks, sweets, sugary beverages, and other foods commonly associated with indulgence and comfort eating. Shift in Consumer Preferences As users of GLP-1 medications experience less hunger and eat smaller portions, they may shift towards more nutrient-dense foods that offer better satiety per calorie, like protein-rich foods, fruits, and vegetables
Demers, A., McNicoll, N., Febbraio, M., Servant, M., Marleau, S., Silverstein, R., & Ong, H
This drug is going to expire this year, with its competitive generics ready to enter the market
Retatrutide appears alongside other experimental or unapproved compounds: Cagrilintide, Tesamorelin, BPC-157, TB-500, GHK-Cu and injectable NAD+
Using two independent bioinformatic tools 29,30 , we found a significant overlap with transcripts associated with genetic susceptibility to obesity in humans, suggesting that GLP-1MK-801 targets biological pathways implicated in common polygenic forms of human obesity 1,31 (Fig
